Immunoisolation of Islets in High Guluronic Acid Barium-Alginate Microcapsules Does Not Improve Graft Outcome at the Subcutaneous Site

Artificial Organs

Volumn 36, Issue 6, 2012, Pages 564-570

  Kerby, Alan ^a   Bohman, Sara ^b   Westberg, Henrik ^b   Jones, Peter ^a   King, Aileen ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alginate; Intraperitoneal; Islet transplantation; Microencapsulation; Subcutaneous

Indexed keywords

CALCIUM; INSULIN; MAMMALS; MICROENCAPSULATION;

ADENOSINE TRIPHOSPHATE; ALGINATE MICROCAPSULES; DEAD CELLS; DIABETIC MICE; GULURONIC ACID; IMMUNO-ISOLATION; INSULIN SECRETION; INTRAPERITONEAL; ISLET TRANSPLANTATION; SUBCUTANEOUS;

ALGINATE;

ADENOSINE TRIPHOSPHATE; ALGINIC ACID; GULURONIC ACID BARIUM ALGINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; INSULIN RELEASE; ISOLATED PANCREAS ISLET; MALE; MICROCAPSULE; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALIA; MUS;

EID: 84862202222     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01411.x     Document Type: Article

References (24)

1. O'Shea GM, Sun AM. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 1986;35:943-6.
2. Fan MY, Lum ZP, Fu XW, Levesque L, Tai IT, Sun AM. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 1990;39:519-22.
3. Soon-Shiong P, Feldman E, Nelson R, etal. Long-term reversal of diabetes in the large animal model by encapsulated islet transplantation. Transplant Proc 1992;24:2946-7.
4. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417-22.
5. De Vos P, Van Straaten JF, Nieuwenhuizen AG, etal. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 1999;48:1381-8.
6. Pileggi A, Molano RD, Ricordi C, etal. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006;81:1318-24.
7. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991;254:1782-4.
8. Tatarkiewicz K, Hollister-Lock J, Quickel RR, Colton CK, Bonner-Weir S, Weir GC. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation 1999;67:665-71.
9. Dufrane D, Steenberghe M, Goebbels RM, Saliez A, Guiot Y, Gianello P. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 2006;27:3201-8.
10. Thanos CG, Bintz BE, Emerich DF. Stability of alginate-polyornithine microcapsules is profoundly dependent on the site of transplantation. J Biomed Mater Res A 2007;81:1-11.
11. Veriter S, Mergen J, Goebbels RM, etal. In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A 2009;16:1503-13.
12. King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 2001;57:374-83.
13. Martinsen A, Skjak-Braek G, Smidsrod O. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng 1989;33:79-89.
14. Kulseng B, Skjak-Braek G, Ryan L, etal. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 1999;67:978-84.
15. Bohman S, King AJ. Isletalpha cell number is maintained in microencapsulated islet transplantation. Biochem Biophys Res Commun 2008;377:729-33.
16. King A, Sandler S, Andersson A, Hellerstrom C, Kulseng B, Skjak-Braek G. Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field. Diabetes Care 1999;22(Suppl. 2):B121-6.
17. Bohman S, Andersson A, King A. No differences in efficacy between noncultured and cultured islets in reducing hyperglycemia in a nonvascularized islet graft model. Diabetes Technol Ther 2006;8:536-45.
18. Korbutt GS, Mallett AG, Ao Z, Flashner M, Rajotte RV. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 2004;47:1810-8.
19. Schrezenmeir J, Hering BJ, Gero L, etal. Long-term function of porcine islets and single cells embedded in barium-alginate matrix. Horm Metab Res 1993;25:204-9.
20. De Carlo E, Baiguera S, Conconi MT, etal. Pancreatic acellular matrix supports islet survival and function in a synthetic tubular device: in vitro and in vivo studies. Int J Mol Med 2010;25:195-202.
21. Fumimoto Y, Matsuyama A, Komoda H, etal. Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. Tissue Eng Part C Methods 2009;15:437-44.
22. Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC. Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 1996;61:1557-61.
23. Kawakami Y, Iwata H, Gu Y, etal. Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation. Cell Transplant 2000;9:729-32.
24. Kawakami Y, Iwata H, Gu YJ, etal. Successful subcutaneous pancreatic islet transplantation using an angiogenic growth factor-releasing device. Pancreas 2001;23:375-81.